Summary
For Year 2026-27, Akums Drugs & Pharmaceuticals reports the following shareholding: Total Promoters at 75.26%, Mutual Fund at 10.95%, Insurance at 0.6%, Foreign Institutional Investors at 1.38%, Domestic Institutional Investors at 2.79%, and Retail at 9.02%. This breakdown provides a quick snapshot of ownership distribution for Akums Drugs & Pharmaceuticals in 2026-27.
Akums Drugs & Pharmaceuticals FAQs
As of 04-2026, the promoter shareholding in Akums Drugs & Pharmaceuticals stands at 75.26% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Akums Drugs & Pharmaceuticals is 1.38% and 2.79% respectively.
The retail shareholding of the Akums Drugs & Pharmaceuticals is 9.02%.
Changes in shareholding patterns of Akums Drugs & Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Akums Drugs & Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Akums Drugs & Pharmaceuticals Associated Pages
- Akums Drugs & Pharmaceuticals Share Price
- Akums Drugs & Pharmaceuticals Share Price chart
- Akums Drugs & Pharmaceuticals Fundamental Analysis
- Akums Drugs & Pharmaceuticals Technical Analysis
- Akums Drugs & Pharmaceuticals Peer Comparison
- Akums Drugs & Pharmaceuticals Share Price History
- Akums Drugs & Pharmaceuticals Board of Directors
